Company intelligence / Profile preview
Organon & Co.
Jersey City, New Jersey, United Statesorganon.com ↗
- Ownership
- Public · OGN
- Employees
- ~10000
- Development stage
- Commercial
01
Overview
Organon has more than sixty commercialized products globally with a strong heritage in women’s health. Its pipeline includes both early-stage assets—such as OG‑6219 for endometriosis now in Phase II—and late-stage/commercial programs. The company has recently expanded through acquisitions and licensing deals for new therapies targeting women’s health needs and biosimilar markets. Clinical results for advanced programs like OG‑6219 are pending completion of ongoing trials expected by late 2024.
- Therapeutic areas
- Women's HealthEndocrinologyNeurologyImmunology
- Modalities
- Small moleculesHormones/peptidesMonoclonal antibodies (biosimilars)Devices (contraceptive implants/rings)
- Industry
- Biotech
02
Drug pipeline
48 assets47 more assets in the full pipeline.
03
Partnerships
Eli Lilly & Company – distribution/promotion of Emgality® and RAYVOW™ for migraine in EuropeSamsung Bioepis – partnership on biosimilars including HADLIMA®/adalimumab-bwwd
04
Financials
- Market cap
- $3.6B
- Total revenue
- $6.2B
- Enterprise value
- $10.7B
Beyond the preview
Go deeper on Organon & Co..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Organon & Co..